Angiogenesis and Multiple Sclerosis Pathogenesis: A Glance at New Pharmaceutical Approaches

Maria Teresa Gentile, Gianluca Muto, Giacomo Lus, Karl-Olof Lövblad, Åsa Fex Svenningsen, Luca Colucci-D'Amato*

*Corresponding author for this work

Research output: Contribution to journalJournal articleResearchpeer-review

28 Downloads (Pure)


Multiple sclerosis is a chronic disease of the central nervous system characterized by demyelination and destruction of axons. The most common form of the disease is the relapsing-remitting multiple sclerosis in which episodic attacks with typical neurological symptoms are followed by episodes of partial or complete recovery. One of the underestimated factors that contribute to the pathogenesis of multiple sclerosis is excessive angiogenesis. Here, we review the role of angiogenesis in the onset and in the development of the disease, the molecular mechanisms underlying angiogenesis, the current therapeutic approaches, and the potential therapeutic strategies with a look at natural compounds as multi-target drugs with both neuroprotective and anti-angiogenic properties
Original languageEnglish
Article number4643
JournalJournal of Clinical Medicine
Issue number16
Number of pages11
Publication statusPublished - 9. Aug 2022


Dive into the research topics of 'Angiogenesis and Multiple Sclerosis Pathogenesis: A Glance at New Pharmaceutical Approaches'. Together they form a unique fingerprint.

Cite this